Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Sertraline 50mg Film Coated Tablet – PA2315/101/003
- Sumatriptan 100mg Tablet – PA2315/070/002
- Zomacton 10mg/ml Powder and Solvent for Solution for Injection – PA1009/008/003
- Zomig 2.5mg Tablet – PA2242/004/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Candist 4mg Tablet – PA0126/206/001
- Cardura 2mg Tablet – PA0822/192/002
- Cozatan 50mg Tablet – PA0126/167/001
- Frumil Low Strength 20mg/2.5mg Tablet – PA0540/101/001
- Genotropin 12mg Powder and Solvent for Solution for Injection – PA0822/128/002
- Hypnovel 10mg/2ml Solution for Injection – PA2239/007/001
- Hytrin 5mg Tablet – PA1142/005/003
- Olmesartan 10mg Tablet – PA2315/113/001
- Pepcid AC 10mg Tablet – PA0330/053/001
- Proctosedyl Ointment – PA0540/062/001
- Raporsin 8mg Prolonged Release Tablet – PA2315/005/001
- Sirdupla 25mcg/250mcg per metered dose Pressurised Inhalation Suspension – PA0577/201/002
- Tavanic 5 mg/ml Solution for Infusion – PA0540/077/001
- Tobi Podhaler 28mg Inhalation Powder; Capsule – EU/1/10/652/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.